Unknown

Dataset Information

0

Edaravone guards dopamine neurons in a rotenone model for Parkinson's disease.

ABSTRACT: 3-methyl-1-phenyl-2-pyrazolin-5-one (edaravone), an effective free radical scavenger, provides neuroprotection in stroke models and patients. In this study, we investigated its neuroprotective effects in a chronic rotenone rat model for Parkinson's disease. Here we showed that a five-week treatment with edaravone abolished rotenone's activity to induce catalepsy, damage mitochondria and degenerate dopamine neurons in the midbrain of rotenone-treated rats. This abolishment was attributable at least partly to edaravone's inhibition of rotenone-induced reactive oxygen species production or apoptotic promoter Bax expression and its up-regulation of the vesicular monoamine transporter 2 (VMAT2) expression. Collectively, edaravone may provide novel clinical therapeutics for PD.

SUBMITTER: Xiong N 

PROVIDER: S-EPMC3108992 | biostudies-literature | 2011

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

3-methyl-1-phenyl-2-pyrazolin-5-one (edaravone), an effective free radical scavenger, provides neuroprotection in stroke models and patients. In this study, we investigated its neuroprotective effects in a chronic rotenone rat model for Parkinson's disease. Here we showed that a five-week treatment with edaravone abolished rotenone's activity to induce catalepsy, damage mitochondria and degenerate dopamine neurons in the midbrain of rotenone-treated rats. This abolishment was attributable at lea  ...[more]

Similar Datasets

Unknown Impaired Wnt signaling in dopamine containing neurons is associated with pathogenesis in a rotenone triggered Drosophila Parkinson's disease model.
| S-EPMC5799194 | biostudies-literature
Unknown Synthesis and Antioxidant Effects of Edaravone-Loaded MPEG-2000-DSPE Micelles in Rotenone-Induced PC12 Cell Model of Parkinson's Disease.
| S-EPMC11643961 | biostudies-literature
Unknown A highly reproducible rotenone model of Parkinson's disease.
| S-EPMC2757935 | biostudies-literature
Unknown Rotenone Induces a Neuropathological Phenotype in Cholinergic-like Neurons Resembling Parkinson's Disease Dementia (PDD).
| S-EPMC11156752 | biostudies-literature
Unknown Soluble epoxide hydrolase inhibitor, APAU, protects dopaminergic neurons against rotenone induced neurotoxicity: Implications for Parkinson's disease.
| S-EPMC6873230 | biostudies-literature
Unknown Taste Impairments in a Parkinson's Disease Model Featuring Intranasal Rotenone Administration in Mice.
| S-EPMC9535587 | biostudies-literature
Unknown Parkinsonism Reversal and Dopaminergic Resilience: Lessons from a Rotenone-induced Parkinson's Disease Model.
| S-EPMC12776045 | biostudies-literature
Unknown Non-Reproducibility of Oral Rotenone as a Model for Parkinson's Disease in Mice.
| S-EPMC9604506 | biostudies-literature
Unknown Neuroprotective and therapeutic effects of calcitriol in rotenone-induced Parkinson's disease rat model.
| S-EPMC9522903 | biostudies-literature
Unknown Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson's disease model.
| S-EPMC7786472 | biostudies-literature